The Huntsville Hospital Health System, also known as Huntsville Hospital, is a public, not-for-profit hospital organization consisting of several sites and buildings originating in the downtown area of Huntsville, Alabama.

There are 941 beds in Huntsville Hospital System.

During the past decade, Huntsville Hospital System conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 11 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Huntsville Hospital System" #1 sponsor was "Radiation Therapy Oncology Group" with 33 trials, followed by "NSABP Foundation Inc" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored and "Endologix" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Huntsville Hospital System" #1 collaborator was "National Cancer Institute (NCI)" with 42 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Huntsville Hospital System" are "Head and Neck Cancer" (8 trials), "Breast Cancer" (6 trials), "Lung Cancer" (6 trials), "Prostate Cancer" (6 trials) and "Brain and Central Nervous System Tumors" (4 trials). Many other conditions were trialed in "Huntsville Hospital System" in a lesser frequency.

Most popular intervention types in "Huntsville Hospital System" are "Drug" (35 trials), "Radiation" (30 trials), "Procedure" (16 trials), "Device" (11 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (26 trials), "conventional surgery" (10 trials), "cisplatin" (7 trials), "paclitaxel" (6 trials) and "filgrastim" (5 trials). Other intervention names were less common.

The vast majority of trials in "Huntsville Hospital System" are 48 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Huntsville Hospital System". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Huntsville Hospital System, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Huntsville Hospital System, 7 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".

Huntsville Hospital System has several departments that took part in Clinical trials: "Tennessee Valley Gynecologic Oncology" - 6 trials, "Alabama Sleep Clinic" - 2 trials